The Middle East & Africa radioactive tracer market was valued at US$ 268.57 million in 2022 and is expected to reach US$ 602.69 million by 2030; it is estimated to grow at a CAGR of 10.6% from 2022 to 2030.
Increasing Use of Nuclear Imaging Techniques fuel the Middle East & Africa Radioactive Tracer Market
PET and SPECT are among the nuclear medicine radiology modalities employed in clinical settings. Their use is increasing as they offer accurate detection, localization, and characterization of diseases. Ionizing radiation for diagnosis and treatment benefits millions of patients globally. Radiation in medicine helps earlier diagnosis and often offers less invasive treatments for human diseases. Advanced radiation technology has opened new horizons in diagnostic and nuclear medicine, radiotherapy, and interventional radiology. According to World Health Organization, over 3,600 million diagnostic radiology examinations are performed, 37 million nuclear medicine procedures are carried out, and 7.5 million radiotherapy treatments are given annually. The development and introduction of new radiopharmaceuticals for PET/CT and SPECT/CT procedures, which are used in novel clinical applications such as neurology and orthopedics, and the growing accuracy of different tumor staging methods contribute to the growth of the radioactive tracer market. For instance, newly introduced cardiac radiopharmaceuticals such as flurpiridaz F-18 and ammonia N-13 help in more precise imaging of cardiovascular conditions. Thus, constant technological advancements for improving the quality and efficacy of nuclear imaging techniques favor the growth of the radioactive tracer market.
Middle East & Africa Radioactive Tracer Market Overview
The Middle East & Africa radioactive tracer market is segmented into UAE, South Africa, Saudi Arabia and the Rest of Middle East & Africa. The regional growth is attributed to technological advancements and developments by market players offering radioactive tracer. Factors such as the rising healthcare infrastructure and the increasing number of chronic diseases, advancements in medical imaging and rising healthcare infrastructure are likely to further propel the market growth during the forecast period.
Middle East & Africa Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Radioactive Tracer Market Segmentation
The Middle East & Africa radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the Middle East & Africa radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.
Based on test type, the Middle East & Africa radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.
Based on end user, the Middle East & Africa radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.
Based on application, the Middle East & Africa radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.
Based on country, the Middle East & Africa radioactive tracer market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa radioactive tracer market share in 2022.
Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, and IBA Radiopharma Solutions are some of the leading players operating in the Middle East & Africa radioactive tracer market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 268.57 Million |
| Market Size by 2030 | US$ 602.69 Million |
| CAGR (2022 - 2030) | 10.6% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Tracer Type
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East & Africa Radioactive Tracer Market is valued at US$ 268.57 Million in 2022, it is projected to reach US$ 602.69 Million by 2030.
As per our report Middle East & Africa Radioactive Tracer Market, the market size is valued at US$ 268.57 Million in 2022, projecting it to reach US$ 602.69 Million by 2030. This translates to a CAGR of approximately 10.6% during the forecast period.
The Middle East & Africa Radioactive Tracer Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Radioactive Tracer Market report:
The Middle East & Africa Radioactive Tracer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Radioactive Tracer Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Radioactive Tracer Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Radioactive Tracer Market
